SARS-CoV2 pneumonia has been a global public health emergency since 2020. The prevalenceof the disease is particularly high with more than 500 million cases worldwide (7.5million in France) since the emergence of the virus.A substantial proportion of patients with SARS-Cov2 infection present persistent symptomslong after the acute infection. This is independent of the degree of severity of theSARS-Cov2 infection.These symptoms can affect the quality of life and impede the return to work. While themajority of symptoms progress favourably with outpatient care, some persist and/or areparticularly severe, justifying expert and multidisciplinary care.This investigation aim to create a clinical database of patients with complex and/orsevere post-CoviD and study blood markers what could predict the disease and orientatenew ways of treatment.
Not Provided
Other: Blood collection
Blood samples will be collected from the patient at baseline. This blood will be
collected during the standard of care blood drawing in extra.
Inclusion Criteria:
All patients who have joined the Epsilon care pathway since its opening in February 2022,
i.e.:
- Patients with post-Covid syndrome referred to the Epsilon sector from the city
medicine:
- Patient with documented SARS-Cov2 pneumonia
- With persistent and severe symptoms beyond 4 weeks or complex or disabling symptoms
beyond 3 months
- Patient over 18 years old.
Post-hospital sector:
- Patient with documented SARS-Cov2 pneumonia
- Hospitalized for oxygen therapy (at least 48h)
- Not having a referring pulmonologist
- Not institutionalized
- With a life expectancy of more than 6 months.
Exclusion Criteria:
- Patient refusing that this data to be used for research purposes (objection form).
- Patient with untreated comorbidities
Department of Acute Pneumology and Thoracic Oncology, Hôpital Lyon Sud, Hospices Civils de Lyon
Pierre-Bénite, France
Investigator: Sébastien COURAUD, Pr
Sebastien.couraud@chu-lyon.fr
Sébastien COURAUD, Pr
+33 (0)4 78 86 44 01
Sebastien.couraud@chu-lyon.fr
Julie DE BERMONT
+33 (0)4 78 86 66 98
Julie.de-bermont@chu-lyon.fr
Sébastien COURAUD, Pr, Principal Investigator
Department of Acute Pneumology and Thoracic Oncology, Hôpital Lyon Sud, Hospices Civils de Lyon